Onera Health has officially launched its Polysomnography-as-a-Service solution, for the diagnosis of sleep disorders, in Europe.
The new sleep diagnostics solution combines a patch-based sensor system with cloud technology to allow healthcare professionals to perform polysomnography anywhere and anytime.
Go deeper with GlobalData
The end-to-end solution is designed for in-lab and at-home sleep diagnostics and monitoring.
Without the need for upfront investment, it requires minimal effort for sleep studies to be conducted with maximum comfort and convenience in patients’ homes.
It uses the companies’ US Food and Drug Administration (FDA)-approved and CE-marked Onera Sleep Test System (STS) along with the Onera Digital Health Platform.
See Also:
The Onera STS sensors are used to capture all the signals required for polysomnography.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataMedical-grade sleep data is captured by four sensors, which are applied to the forehead, upper chest, abdominal area and lower leg using patches.
These no-wire sensors provide a complete polysomnography signal set that includes electroencephalogram (EEG), electromyography (EMG), electrooculography (EOG) and electrocardiogram (ECG).
Additionally, sound pressure (to detect snoring), respiratory measurements, body motion and body position, and electromyography leg data are also collected.
The Onera Digital Health Platform manages the data, securely directing it within the networks of clinics and providers.
Onera Health CEO Ruben de Francisco said: “For many years, comprehensive sleep diagnostics was mainly possible in in-patient laboratories that required significant resources, resulting in long waiting times and often poor patient experience.
“Our innovative solution enables large-scale utilisation of at-home polysomnography.
“This will not only increase patient comfort during a sleep study significantly, it will also improve access and shorten the diagnostic journeys of patients suffering from sleep disorders.”
The company stated that the new sleep diagnostics solution will be available in Germany and The Netherlands this year, with plans for its launch in other European countries to follow.
